Cart 0
Collagen Therapy for Chronic Eczema – Eczema is one of the most common chronic inflammatory skin conditions, affecting millions of people worldwide. Characterized by dry, itchy, inflamed skin and recurring flare-ups, eczema can significantly impact daily life and quality of life. Persistent itching often leads to scratching, which further damages the skin and increases the risk of infection.
Traditional eczema treatment focuses on controlling inflammation, relieving itching, and restoring the skin barrier with moisturizers, topical corticosteroids, calcineurin inhibitors, and other medications depending on disease severity. However, advances in regenerative dermatology are shifting the conversation beyond symptom management. Researchers are now exploring therapies that may help repair damaged skin tissue itself.
One emerging approach is collagen therapy using Collost. A publication from Collost Global, “Collagen Therapy in the Treatment of Chronic Eczema”, discusses how native collagen may serve as an adjunctive treatment by supporting skin regeneration in patients with chronic eczema. While this approach is not intended to replace standard medical treatment, it represents an innovative strategy aimed at improving skin repair alongside conventional therapy. Learn more now.
What Is Eczema?
Eczema, most commonly atopic dermatitis, is a chronic inflammatory skin disease that causes dry, itchy, irritated, and inflamed skin. Eczema develops through a combination of genetic factors, immune system dysfunction, environmental triggers, and an impaired skin barrier.
In healthy skin, the outermost layer acts as a protective shield that keeps moisture in while blocking irritants, allergens, bacteria, and pollutants. In people with eczema, this protective barrier becomes compromised. As a result, moisture escapes more easily, while external irritants penetrate the skin more readily, triggering inflammation and itching.
Eczema is not contagious, but it tends to follow a lifelong pattern of flare-ups and remission. In chronic cases, repeated inflammation and scratching may lead to thickened skin, discoloration, cracks, and long-term damage to the skin’s structure.
Why Is Chronic Eczema Difficult to Treat?
One of the biggest challenges in managing eczema is that it is a chronic condition. Even when symptoms improve, the skin may not have fully recovered beneath the surface. The skin barrier often remains fragile, making it vulnerable to future flare-ups.
Long-standing inflammation also affects deeper layers of the skin. Over time, repeated inflammatory episodes can alter the dermis, including the collagen network responsible for maintaining skin strength, elasticity, and structural integrity. This contributes to slower healing and leaves the skin thinner and more susceptible to injury.
Because of these challenges, researchers have become increasingly interested in regenerative therapies that not only reduce inflammation but also help restore damaged skin tissue.
What Is Collagen Therapy with Collost?
According to the publication “Collagen Therapy in the Treatment of Chronic Eczema,” by Collost Global, Collost is a native type I collagen biomaterial developed to support tissue regeneration. Unlike oral collagen supplements or topical skincare products that primarily work on or through the skin’s surface, Collost is administered through intradermal injections, allowing collagen to be delivered directly into the affected tissue.
The publication explains that native collagen closely resembles the body’s own collagen structure. Once injected, it functions as a biological scaffold, which is a temporary framework that supports cell migration, tissue repair, and the formation of new extracellular matrix.
Rather than simply addressing symptoms, this regenerative approach aims to create a healthier environment within the skin, allowing natural healing processes to occur more effectively.
How Does Collost Work in Managing Eczema?
The clinical publication suggests that chronic eczema often disrupts the skin’s natural regenerative capacity due to persistent inflammation. Damaged tissue struggles to rebuild itself efficiently, resulting in prolonged healing and recurring skin breakdown.
Collost is designed to provide a collagen matrix that supports several biological processes involved in tissue repair. The injected collagen acts as a structural framework that encourages cell migration, promotes angiogenesis (the formation of new blood vessels), and stimulates the body’s own collagen production.
As new tissue develops within this scaffold, the skin may gradually regain improved structural organization. According to the publication, strengthening the dermal architecture may also contribute to better skin barrier function, making the skin more resilient against repeated irritation.
Importantly, the authors emphasize that Collost is intended as an adjunctive regenerative therapy, not a replacement for established eczema treatments.
What Are the Results of Collagen Therapy on Eczema?
The publication presents a clinical case involving the use of Collost as part of the treatment strategy for chronic eczema. Following multiple treatment sessions performed according to the recommended protocol, improvements were observed in several aspects of the patient’s skin condition.
The treated areas demonstrated healthier skin texture, reduced dryness, and improved tissue regeneration. The publication also described a reduction in the severity of chronic lesions and an overall enhancement in skin quality during follow-up.
While these findings are encouraging, the authors acknowledge that the report represents clinical experience rather than large-scale clinical evidence. Additional studies involving larger patient populations will be necessary to better evaluate the effectiveness, safety, and long-term outcomes of collagen therapy in eczema management.
Can Collagen Therapy Replace Conventional Eczema Treatment?
The answer is no. Current international treatment guidelines continue to recommend therapies that control inflammation and relieve symptoms based on disease severity. These include daily moisturizers, topical corticosteroids, topical calcineurin inhibitors, biologic medications, and systemic therapies for more severe cases.
Collost should therefore be viewed as a supportive regenerative treatment rather than a substitute for evidence-based eczema management. Its proposed role is to complement standard therapy by assisting tissue repair after or alongside inflammation control.
Patients should continue following the treatment plan recommended by their dermatologist while discussing whether regenerative options may be appropriate for their individual condition.
Who May Benefit from This Approach?
Based on publication, collagen therapy may be considered for patients with chronic eczema accompanied by long-term structural skin damage. Because the procedure involves intradermal injections, it should only be performed by qualified healthcare professionals experienced in dermatology or aesthetic medicine.
Not every person with eczema requires regenerative collagen therapy. Treatment decisions should always be individualized, taking into account the severity of eczema, the condition of the skin, medical history, and the patient’s treatment goals.
A comprehensive medical evaluation is essential before determining whether this type of therapy may be appropriate.
Read More:
- https://pyfaesthetic.com/all-about-collost-the-masterpiece-of-native-collagen-type-i/
- https://pyfaesthetic.com/collost-micro-the-secret-behind-radiant-skin/
Conclusion
Eczema is a chronic inflammatory skin disease that affects not only the skin’s surface but also its deeper structural components over time. While conventional treatments remain the foundation of eczema management, regenerative strategies are beginning to attract attention for their ability to support tissue repair.
Collost utilizes native type I collagen as a biological scaffold that helps create an environment favorable for skin regeneration. Early clinical observations suggest improvements in skin texture, hydration, tissue quality, and chronic lesion appearance following treatment.
However, it is important to recognize that collagen therapy is currently considered a complementary regenerative approach, not a replacement for established eczema treatments. Larger clinical studies are still required to confirm its long-term efficacy and safety across broader patient populations.
Sources:
- https://collost.global/publications/collagen-therapy-in-the-treatment-of-chronic-eczema.
- https://my.clevelandclinic.org/health/diseases/9998-eczema.
- https://svensisland.com.au/blogs/skin/eczema-in-adults?srsltid=AfmBOorLkFCWQJtjVhiqL7pIZWRE3VtF0NYyy59vJ6wbbMZjepGctgKP.